Thursday, August 26, 2021

AVTE Aerovate Therapeutics Inc


AVTE is a 2 month old IPO that dropped from day one by more than 50% from the highs. The stock has been searching for a bottom around $12 for several weeks, the DI's just crossed, the RSI moving up quickly to 47, and today we get a nice green candle above the 10sma on good volume.

Is this finally the bottom that we have been waiting for?

4 analysts have it rated as a Strong Buy with one year price targets between $21-$30.